Leveraging Antibody-Toxin Conjugates to Achieve Selective & Functional Ion Channel Modulation

  • Exploiting toxin-derived mechanisms and extracellular epitopes to overcome selectivity challenges in highly conserved ion channel families
  • Designing antibody-based ion channel therapeutics that combine functional modulation with improved subtype discrimination
  • Translating platform capabilities from in vitro electrophysiology through in vivo preclinical models across multiple therapeutic indications